hotspot -WSS

hotspot

author：hotspot 2025-09-27 12:57:57 - browse：8

Boxes of Ozempic photo illustration. -- health coverage from STAT — Mario Tama/Getty Images

LONDON — Novo Nordisk’s diabetes medication Ozempic cut the risk of patients developing advanced kidney disease or dying from kidney or heart complications, the company said Tuesday, adding to the evidence the wildly popular drug has broader health benefits for patients beyond addressing their diabetes.

Overall, Ozempic lowered the risk of progression of patients’ kidney disease and of related health events by 24% versus placebo, according to the topline results. The company, which will present full data from the study later this year, said it would file for an expanded approval of Ozempic based on the data in both the U.S. and Europe.

The positive announcement had been expected since October, when Novo announced it was ending the FLOW trial early because an interim data analysis showed the drug was surpassing the study’s goals. Still, the results provide an important data point for Novo both as its medicines face increasing competition and as it tries to get more insurers to cover its related obesity drug Wegovy.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Medicare proceeds with plan to claw back hospital funds

WSS

ThunderShirts, dance parties and anxiety meds can help ease dogs' July Fourth dread

Life sciences investors close nearly $6 billion in new funds

1 dead, 9 hurt in July 4th fireworks explosion

NASA releases new images of 'fingerprint

Russians and Belarusians back at Wimbledon as war in Ukraine continues

Kremlin open to talks over potential prisoner swap involving detained US reporter Evan Gershkovich

hotspot

hotspot

explore

Affirmative action in medical school literally saved lives

PlayStation controller and acoustic messaging: How the missing Titanic tourist sub works

At least 13 dead in Texas as scorching temps continue

The Democratic Party promised to overhaul its primaries. Doing that has been anything but simple

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Some in Scotland's Orkney Islands want to return to Norway after 550 years

Medicare details structure of new drug price negotiation program

Masked assailants attack a journalist and a lawyer in Russia's Chechnya province

Anesthesiologist group: stop taking Ozempic before surgery

Michigan man accused of striking an officer during the US Capitol attack is arrested in Florida

hotspot

Trump pressured former Arizona governor to overturn 2020 election results: Sources

July 4th fireworks can be stressful for dogs. These 6 tips can keep them calm and safe

Infant mortality in U.S. rose last year for first time in decades: CDC

The Democratic Party promised to overhaul its primaries. Doing that has been anything but simple

ThunderShirts, dance parties and anxiety meds can help ease dogs' July Fourth dread

Noem? Reynolds? A very early look at the Republican 'veepstakes'

entertainment

Wikipedia

knowledge

explore